Next Article in Journal
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature
Next Article in Special Issue
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
Previous Article in Journal
Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma
Previous Article in Special Issue
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown
 
 
Review

Article Versions Notes

Cancers 2020, 12(11), 3316; https://doi.org/10.3390/cancers12113316
Action Date Notes Link
article pdf uploaded. 10 November 2020 10:52 CET Version of Record -
article xml file uploaded 10 November 2020 11:10 CET Original file -
article xml uploaded. 10 November 2020 11:10 CET Update https://www.mdpi.com/2072-6694/12/11/3316/xml
article pdf uploaded. 10 November 2020 11:10 CET Updated version of record https://www.mdpi.com/2072-6694/12/11/3316/pdf
article html file updated 10 November 2020 11:12 CET Original file -
article html file updated 23 July 2022 00:28 CEST Update https://www.mdpi.com/2072-6694/12/11/3316/html
Back to TopTop